Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
234.4 EUR | +0.60% |
|
+0.73% | -18.44% |
06-28 | Would you like some more inflation? | ![]() |
06-28 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
122B | ||||||
112B | ||||||
25.91B | - | |||||
19.33B | - | |||||
15.56B | - |
- Stock Market
- Equities
- GMAB Stock
- GE9 Stock
- Charts Genmab A/S
- Sector Chart